Clinical Trials Browser

Phase 2 × OTHER × TLC 388 × Clear all

NCT02457273 2019-04-03

Phase II Study to Evaluate the Efficacy and Safety of TLC388 for Differentiated Neuroendocrine Carcinomas Patients

Phase 2 Completed

Carcinoma, Neuroendocrine